EcoDrugPlus

Integrin Subunit Alpha 4

Ensembl ID : ENSFCAG00000010843
Gene Symbol: ITGA4
5 Cross references
237 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSFCAG00000010155
Gene Symbol: ITGA5
5 Cross references
267 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSFCAG00000005653
Gene Symbol: ITGAV
5 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSFCAG00000019338
Gene Symbol: ITGB1
5 Cross references
301 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSFCAG00000003880
Gene Symbol: ITGB3
5 Cross references
268 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSFCAG00000015093
Gene Symbol: ITGB5
5 Cross references
212 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSFCAG00000023012
Gene Symbol: ITGB6
5 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSFCAG00000005869
Gene Symbol: ITGB7
5 Cross references
159 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSFCAG00000006893
Gene Symbol: ITGB8
5 Cross references
207 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSFCAG00000009431
Gene Symbol: ICAM1
5 Cross references
88 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSFCAG00000021974
Gene Symbol: IRAK4
5 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSFCAG00000013321
Gene Symbol: IL5
5 Cross references
91 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).